U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06827483) titled 'Adding Neurocognitive Component to Balance Test' on Feb. 03.
Brief Summary: By introducing BlazePods as a neurocognitive addition to the YBT, this study aims to determine whether this addition impacts balance performance and/or reach distances between the operative and non-operative limbs of patients recovering from ACL reconstruction. Findings will contribute to optimizing return-to-sport protocols and enhancing late-stage rehabilitation program designs.
Study Start Date: Feb. 15
Study Type: OBSERVATIONAL
Condition:
Anterior Cruciate Ligament Injuries
Intervention:
OTHER: Neurocognitive Component
A neurocognitive component w...